Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia
World Journal of Gastroenterology, 11/02/09
Antonelli A et al. – The study demonstrates high levels of circulating NTproBNP and TNF–alpha in MC+HCV patients. The increase of NTproBNP may indicate the presence of a subclinical cardiac dysfunction.
Related Articles
Acute wrist and foot drop associated with hepatitis C virus related mixed cryoglobulinemia: Rapid response to treatment with rituximab
Journal of Clinical Virology, 11/11/09
Relevance Score: 84%
Non–hepatitis virus associated mixed essential cryoglobulinemia
Kidney International, 11/05/09
Relevance Score: 82%
Membranoproliferative glomerulonephritis
Pediatric Nephrology, 11/16/09
Relevance Score: 77%
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation
Core Evidence, 12/11/09
Folate intake, post–folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
American Journal of Clinical Nutrition, 12/11/09
Hepatic steatosis in overweight/obese females: New screening method for those at risk
World Journal of Gastroenterology, 12/11/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Zoledronic acid: an unending tale for an antiresorptive agent
Expert Opinion in Pharmacotherapy, 12/11/09
HER-2 targeted treatment of osteosarcoma: the challenges of developing targeted therapy and prognostic factors for rare malignancies
Expert Opinion in Pharmacotherapy, 12/11/09
Risk of additional cancers in untreated and treated hairy cell leukemia patients
Expert Opinion in Pharmacotherapy, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


